CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
PREDICTIVE VALUE OF BASELINE AND ON-TREATMENT qHBsAg LEVEL IN HBeAg POSITIVE CHB PATIENTS WHO SWITCHED FROM NUCS TO PEGYLATED INTERFERON A-2A: A FURTHER ANALYSIS FROM NEW SWITCH STUDY 会议论文
作者:  Hu, P.;  Shang, J.;  Zhang, W.;  Gong, G.;  Li, Yongguo
收藏  |  浏览/下载:10/0  |  提交时间:2019/12/19
A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文
作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace